Name | 2-Hydroxy-4-({6-[(5Z)-5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]hexanoyl}amino)benzoic acid |
---|---|
Synonyms |
Benzoic acid, 2-hydroxy-4-[[6-[(5Z)-5-[(4-methylphenyl)methylene]-4-oxo-2-thioxo-3-thiazolidinyl]-1-oxohexyl]amino]-
MFCD04423481 2-Hydroxy-4-({6-[(5Z)-5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]hexanoyl}amino)benzoic acid F1063-0967 |
Description | F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM. |
---|---|
Related Catalog | |
Target |
IC50: 11.62 μM (DUSP26)[1] |
In Vitro | F1063-0967 is a Dual-specificity phosphatase 26 (DUSP26) inhibitor with an IC50 of 11.62 μM. At concentration above 0.1 μM, F1063-0967 remarkably induces IMR32 cell apoptosis. F1063-0967 induces apoptosis in IMR-32 cell line with an IC50 value of 4.13 μM. F1063-0967 has no effect on HL7702 cell line, and little inhibition effect on SH-SY5Y cell line[1]. |
Cell Assay | The IMR-32 cells are plated in 96-well plates with 1×103 cells per well. After the cells are allowed to settle for 24 h, F1063-0967 (0, 10, 1, and 0.1 μM) is added. An MTTassay is performed. For cell lines HL7702 and SH-SY5Y, the cells are allowed to settle for 24 h, F1063-0967 (10 μM) is added, then MTT assays are carried out after 72 h[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C24H24N2O5S2 |
Molecular Weight | 484.588 |
Exact Mass | 484.112671 |
LogP | 5.03 |
Index of Refraction | 1.704 |
Storage condition | 2-8℃ |